Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Venous Disease: early-phase trial registry
3 of 7 indexed Venous Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Venous Disease: 7 US clinical trials tracked, 3 recruiting.
Venous Disease is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is W.L.Gore & Associates, running 2 of these trials.
Enrollment posture brief
Registry condition venous-disease
OPEN 3 | RECR 43% | LATE 0 | EARLY 1 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)
Venous Disease lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Venous Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Venous Disease is recruiting below its size-band peers.
3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Venous Disease research.
W.L.Gore & Associates accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Venous Disease enrolment sits around 165 participants.
Median target enrolment is 165 among the 7 trials that report a genuine target (sentinel values excluded). 2 of those (28.6%) plan for fewer than 100 participants.
-
Venous Disease splits between interventional and observational designs.
4 interventional and 3 observational studies make up this index (57.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Vascular Lab Resource (VLR) Biorepository
The Cleveland Clinic
NCT05628948
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
W.L.Gore & Associates
NCT05489588
US Post-Market Surveillance Study of the Surfacer System
Merit Medical Systems
NCT05050799
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
W.L.Gore & Associates
NCT05409976
Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation
Medical University of South Carolina
NCT01509599
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
C. R. Bard
NCT02655887
Prevalence of MTHFR Polymorphisms in Venous Disease
Health Diagnostic Laboratory
NCT01993914
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Venous Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Venous Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Venous Disease page
7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Venous Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- W.L.Gore & Associates sponsors the most Venous Disease trials on record, review their full trial history before evaluating a specific study. See W.L.Gore & Associates's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Venous Disease condition card totals 7 registered trials; most-linked intervention GORE® VIAFORT Vascular Stent; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.